BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Recent success of LNP safety has put the industry back in the 
 spotlight. From personalized CRISPR treatments and Capstan's phase I tria
 l initiation for autoimmune diseases\, to Verve's recent clinical progres
 s to lower cholesterol\; these headlines have reignited the hope for LNPs
  to solve the biggest hurdles in drug delivery.\n\nThe 4th LNP Immunogeni
 city and Toxicity returns in December\, as an industry-dedicated virtual 
 forum\, bringing you the key updates on pre-clinical and clinical safety 
 assessments and assays to effectively measure and monitor LNP safety for 
 gene and cell therapies and vaccine applications.\n\nThis year's exclusiv
 e one-day program will provide you with an entire day of scientific progr
 ess and technical insights into LNP mechanism of action\, translational a
 nimal model approaches\, and pharmacokinetic and dynamic studies to suppo
 rt the prediction\, dosing strategy\, and improve clinical effectiveness 
 of pegylated and ionizable LNPs across all payloads.\n\nLog on to the pla
 tform from the comfort or your home or office and connect with 80+ fellow
  LNP experts spanning non-clinical and clinical safety\, from immunology\
 , toxicology\, pharmacology\, and bioanalytics to learn\, share\, and net
 work virtually to support the development of safer LNPs for patients fast
 er.\n\nDate and Time: Wednesday\, 03 December 2025 at 08:30 - 17:00\n
DTEND:20251203T170000
DTSTAMP:20260512T220029Z
DTSTART:20251203T083000
LOCATION:Online\, Virtual\, Digital\, 00000\,
SEQUENCE:0
SUMMARY:Recent success of LNP safety has put the industry back in the spot
 light. From personalized CRISPR treatments and Capstan's phase I trial in
 itiation...
UID:d1152806-3420-448c-ba06-6adf9c40d9b6
END:VEVENT
END:VCALENDAR